Systematic Review of Cysteine-Sparing NOTCH3 Missense Mutations in Patients with Clinical Suspicion of CADASIL
- PMID: 28902129
- PMCID: PMC5618613
- DOI: 10.3390/ijms18091964
Systematic Review of Cysteine-Sparing NOTCH3 Missense Mutations in Patients with Clinical Suspicion of CADASIL
Abstract
CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy) is caused by mutations in the NOTCH3 gene, affecting the number of cysteines in the extracellular domain of the receptor, causing protein misfolding and receptor aggregation. The pathogenic role of cysteine-sparing NOTCH3 missense mutations in patients with typical clinical CADASIL syndrome is unknown. The aim of this article is to describe these mutations to clarify if any could be potentially pathogenic. Articles on cysteine-sparing NOTCH3 missense mutations in patients with clinical suspicion of CADASIL were reviewed. Mutations were considered potentially pathogenic if patients had: (a) typical clinical CADASIL syndrome; (b) diffuse white matter hyperintensities; (c) the 33 NOTCH3 exons analyzed; (d) mutations that were not polymorphisms; and (e) Granular osmiophilic material (GOM) deposits in the skin biopsy. Twenty-five different mutations were listed. Four fulfill the above criteria: p.R61W; p.R75P; p.D80G; and p.R213K. Patients carrying these mutations had typical clinical CADASIL syndrome and diffuse white matter hyperintensities, mostly without anterior temporal pole involvement. Cysteine-sparing NOTCH3 missense mutations are associated with typical clinical CADASIL syndrome and typical magnetic resonance imaging (MRI) findings, although with less involvement of the anterior temporal lobe. Hence, these mutations should be further studied to confirm their pathological role in CADASIL.
Keywords: CADASIL; NOTCH3; cysteine; mutation; temporal pole.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Phenotypes Associated with NOTCH3 Cysteine-Sparing Mutations in Patients with Clinical Suspicion of CADASIL: A Systematic Review.Int J Mol Sci. 2024 Aug 13;25(16):8796. doi: 10.3390/ijms25168796. Int J Mol Sci. 2024. PMID: 39201482 Free PMC article.
-
Intracerebral Hemorrhage in Patients With CADASIL: Additive Impact of the NOTCH3 R544C Variant and Hypertension?Stroke. 2025 Aug;56(8):2159-2166. doi: 10.1161/STROKEAHA.124.050484. Epub 2025 Apr 24. Stroke. 2025. PMID: 40270244
-
Contribution of "Omic" Studies to the Understanding of Cadasil. A Systematic Review.Int J Mol Sci. 2021 Jul 8;22(14):7357. doi: 10.3390/ijms22147357. Int J Mol Sci. 2021. PMID: 34298974 Free PMC article.
-
Association Between Vascular NOTCH3 Aggregation and Disease Severity in a CADASIL Cohort - Implications for NOTCH3 Variant-Specific Disease Prediction.Ann Neurol. 2025 Aug;98(2):273-285. doi: 10.1002/ana.27240. Epub 2025 Apr 23. Ann Neurol. 2025. PMID: 40265482 Free PMC article.
-
Comparison of clinical and imaging features of cerebral small vessel disease associated with heterozygous HTRA1 and NOTCH3 mutations.Int J Stroke. 2025 Jul 3:17474930251359110. doi: 10.1177/17474930251359110. Online ahead of print. Int J Stroke. 2025. PMID: 40607620
Cited by
-
Genotype and Phenotype Differences in CADASIL from an Asian Perspective.Int J Mol Sci. 2022 Sep 29;23(19):11506. doi: 10.3390/ijms231911506. Int J Mol Sci. 2022. PMID: 36232798 Free PMC article. Review.
-
Notch3 Signaling and Aggregation as Targets for the Treatment of CADASIL and Other NOTCH3-Associated Small-Vessel Diseases.Am J Pathol. 2021 Nov;191(11):1856-1870. doi: 10.1016/j.ajpath.2021.03.015. Epub 2021 Apr 22. Am J Pathol. 2021. PMID: 33895122 Free PMC article. Review.
-
A novel cysteine-sparing G73A mutation of NOTCH3 in a Chinese CADASIL family.Neurogenetics. 2020 Jan;21(1):39-49. doi: 10.1007/s10048-019-00592-3. Epub 2019 Nov 13. Neurogenetics. 2020. PMID: 31720972
-
Update on the Epidemiology, Pathogenesis, and Biomarkers of Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy.J Clin Neurol. 2023 Jan;19(1):12-27. doi: 10.3988/jcn.2023.19.1.12. J Clin Neurol. 2023. PMID: 36606642 Free PMC article. Review.
-
Structural changes in NOTCH3 induced by CADASIL mutations: Role of cysteine and non-cysteine alterations.J Biol Chem. 2023 Jun;299(6):104838. doi: 10.1016/j.jbc.2023.104838. Epub 2023 May 19. J Biol Chem. 2023. PMID: 37209821 Free PMC article.
References
-
- Tournier-Lasserve E., Joutel A., Melki J., Weissenbach J., Lathrop G.M., Chabriat H., Mas J.L., Cabanis E.A., Baudrimont M., Maciazek J., et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12. Nat. Genet. 1993;3:256–259. doi: 10.1038/ng0393-256. - DOI - PubMed
-
- Joutel A., Corpechot C., Ducros A., Vahedi K., Chabriat H., Mouton P., Alamowitch S., Domenga V., Cecillion M., Marechal E., et al. NOTCH3 mutations in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), a mendelian condition causing stroke and vascular dementia. Ann. N. Y. Acad. Sci. 1997;826:213–217. doi: 10.1111/j.1749-6632.1997.tb48472.x. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous